114 related articles for article (PubMed ID: 7549229)
21. Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells.
Provencher PH; Saltis J; Funder JW
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):219-25. PubMed ID: 7696142
[TBL] [Abstract][Full Text] [Related]
22. Influence of parainfluenza-1 respiratory tract viral infection on endothelin receptor-effector systems in mouse and rat tracheal smooth muscle.
Knott PG; Henry PJ; McWilliam AS; Rigby PJ; Fernandes LB; Goldie RG
Br J Pharmacol; 1996 Sep; 119(2):291-8. PubMed ID: 8886411
[TBL] [Abstract][Full Text] [Related]
23. Plasticity of contractile endothelin-B receptors in human arteries after organ culture.
Adner M; Cantera L; Ehlert F; Nilsson L; Edvinsson L
Br J Pharmacol; 1996 Nov; 119(6):1159-66. PubMed ID: 8937719
[TBL] [Abstract][Full Text] [Related]
24. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
Seo B; Lüscher TF
Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
[TBL] [Abstract][Full Text] [Related]
25. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
26. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II-mediated potentiation of endothelin-1-evoked bronchial contractions: a role for leukotrienes?
Pitt CM; Nally JE
Pulm Pharmacol Ther; 1999; 12(1):7-12. PubMed ID: 10208831
[TBL] [Abstract][Full Text] [Related]
28. Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat.
Pape D; Goineau S; Guillo P; Durand-Castel X; Bellissant E
Fundam Clin Pharmacol; 1999; 13(4):461-7. PubMed ID: 10456287
[TBL] [Abstract][Full Text] [Related]
29. Endothelin receptors and calcium translocation pathways in human airways.
Hay DW; Luttmann MA; Muccitelli RM; Goldie RG
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):404-10. PubMed ID: 10498291
[TBL] [Abstract][Full Text] [Related]
30. Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder.
Donoso MV; Salas C; Sepúlveda G; Lewin J; Fournier A; Huidobro-Toro JP
Br J Pharmacol; 1994 Feb; 111(2):473-82. PubMed ID: 8004392
[TBL] [Abstract][Full Text] [Related]
31. Ca2+ signalling by endothelin receptors in rat and human cultured airway smooth muscle cells.
Maxwell MJ; Goldie RG; Henry PJ
Br J Pharmacol; 1998 Dec; 125(8):1768-78. PubMed ID: 9886769
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological and molecular biological evidence for ETA endothelin receptor subtype mediating mechanical responses in the detrusor smooth muscle of the human urinary bladder.
Okamoto-Koizumi T; Takeda M; Komeyama T; Hatano A; Tamaki M; Mizusawa T; Tsutsui T; Obara K; Tomita Y; Arai K; Takahashi K
Clin Sci (Lond); 1999 Apr; 96(4):397-402. PubMed ID: 10087247
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
35. Developmental changes in response to endothelins and receptor subtypes of isolated rat duodenum.
Irie K; Uchida Y; Fujii E; Muraki T
Eur J Pharmacol; 1995 Feb; 275(1):45-51. PubMed ID: 7774661
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity in vascular smooth muscle responsiveness to angiotensin II. Role of endothelin.
Chen L; McNeill JR; Wilson TW; Gopalakrishnan V
Hypertension; 1995 Jul; 26(1):83-8. PubMed ID: 7607737
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature.
Moreland S; McMullen D; Abboa-Offei B; Seymour A
Br J Pharmacol; 1994 Jun; 112(2):704-8. PubMed ID: 8075891
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II receptors in the rat urinary bladder smooth muscle: type 1 subtype receptors mediate contractile responses.
Tanabe N; Ueno A; Tsujimoto G
J Urol; 1993 Sep; 150(3):1056-9. PubMed ID: 8345584
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
Cox SL; Story DF; Ziogas J
Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
[TBL] [Abstract][Full Text] [Related]
40. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
Leskinen H; Vuolteenaho O; Ruskoaho H
Circ Res; 1997 Jan; 80(1):114-23. PubMed ID: 8978330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
